David Arkowitz, Chief Financial Officer at Flexion Therapeutics Inc (FLXN), sold 2,229 shares at $7.23 ($16K) on 2021-05-10, disclosed to the SEC on 2021-05-12.
Open-market sale of $16k FLXN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MCRB | SELL | 2023-10-31 | $5K | — | Filing → |
| FLXN | SELL | 2021-01-07 | $135K | — | Filing → |
| FLXN | SELL | 2020-05-11 | $26K | — | Filing → |